Missouri Legislator Introduces Psilocybin Bill

Missouri Legislator Introduces Psilocybin Bill
High Times

Missouri Rep. Tony Lovasco introduced House Bill 869 on Jan. 18 that would allow psilocybin therapy, which is a revised version of a bill that he introduced in 2022.  Under the current bill text, it would allow patients to use psilocybin to treat conditions such as depression or post-traumatic stress disorder, as well as those who are terminally ill and suffering from mental health. It would also cover patients who have undergone treatments for other conditions that were unsuccessful. Lovasco described his bill as “a first step to addressing pervasive mental health crises that affect every sector of our society and economy by creating access to clinically validated therapies,” Lovasco stated in a press release. “I am especially encouraged at clinical research suggesting psilocybin may be a tool to address our opiate addiction crisis.” Under HB 869, the Department of Health and Senior Services (DHSS) would be in charge of regulating psilocybin therapy, including opening up the treatment option to other qualifying conditions in the future. Anyone would be able to petition the DHSS to include a new condition that “benefits persons with the proposed condition in a manner equal to or greater than the benefit.” Lovasco’s previous iteration of the bill, House Bill 2850, was introduced on March 1, 2022. It was given a hearing at the House Health and Mental Health Policy Committee on March 28, 2022, but did not move forward after that. The text originally mentioned ibogaine and mescaline, which has since been removed. HB-869 now allows treatment options to expand if psilocybin is rescheduled under the Controlled Substances Act. If rescheduling occurs, it would allow any Missourian to become a patient as long as they are 21 or older to be eligible. Although it’s uncertain what the fate of HB-869 will be, the topic of…

Excerpt only …
READ MORE BELOW
Source : Missouri Legislator Introduces Psilocybin Bill

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.